RIRidho Islamie

Ridho Islamie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ridho Islamie has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medicinal Plants for Hemorrhoid Therapy: Mechanistic Insights, Bioactive Compounds, and Preclinical-to-Clinical Evidence

    by Muhammad Rizal Januardi, Finna Setiawan, Ridho Islamie, Johan Sukweenadhi, Boonsong Wungsintaweekul, Kartini Kartini

    Hemorrhoid is a multifactorial condition involving inflammation, venous stasis, degeneration of supporting tissue, and vascular fragility. It requires safer adjunctive therapy options for long-term use. This narrative review seeks to comprehensively examine potential anti-hemorrhoidal medicinal plants by linking bioactive compounds, pharmacological targets, and evidence from in vitro , in vivo , and clinical trials. Literature searches were conducted using PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar, focusing on original research articles that documented anti-inflammatory, antioxidant, venoprotective-venotonic, hemostatic-astringent, analgesic, and wound healing activities. The articles were further synthesized qualitatively according to the pathophysiology of hemorrhoids. A total of 90 articles met the inclusion criteria and were classified based on the predominant mechanism, namely anti-inflammatory–antioxidant agents (14 plants; 41 articles), vasoprotective–venotonic agents (6 plants; 10 articles), astringent–hemostatic agents (6 plants; 14 articles), and analgesic and wound healing acceleration (7 plants; 25 articles). The findings showed that medicinal plants operate through a multitarget manner by suppressing inflammatory mediators, increasing endogenous antioxidant defenses, improving venous tone and microvascular stability, supporting local hemostasis, and accelerating mucosal regeneration. Nonetheless, the evidence remains predominantly derived from preclinical studies, with variations in extraction methods, formulations, routes of administration, and dosages. Overall, medicinal plants have potential as adjuvant therapy for hemorrhoids; nevertheless, standardization of extracts and controlled clinical trials are necessary to ensure efficacy and safety.

  • Open Access

    Dicaffeoylquinic Acid–Rich Sunflower Sprout Extract Attenuates High‐Fat Diet‐Induced Obesity in Rats

    by Suwichak Chaisit, Vudhiporn Limprasutr, Ausana Wongtayan, Ridho Islamie, Ketthida Cheevarungnapakul, Supaart Sirikantaramas, Ratchanee Rodsiri

    Obesity is a major hallmark of metabolic syndrome and is strongly associated with an increased risk of cardiovascular disease progression. Sunflower sprouts are a particularly rich source of caffeoylquinic acids (CQAs), compounds recognized for their capacity to attenuate weight gain and mitigate dyslipidemia. Sunflower sprout extract (SSE) used in this study was enriched in dicaffeoylquinic acids (diCQAs) and chlorogenic acid (5‐CQA). To evaluate its effects, male Wistar rats were first induced to develop obesity by receiving a high‐fat diet for four months, after which they were given daily oral administration of SSE for an additional 12 weeks. The effects of SSE against HFD‐induced obesity were evaluated by examining liver pathology, antioxidant activity, and biochemistry, including lipid profiles and liver and renal functions. Body weight, food intake, biochemistry, and complete blood count (CBC) were monitored for 12 weeks. SSE treatment significantly decreased body weight gain (at 4 and 8 weeks), food intake (at 8 weeks), triglyceride levels (at 4 weeks), and low‐density lipoprotein (LDL) levels (at 12 weeks) in HFD rats. Total cholesterol, ALT, ALP, BUN, and uric acid levels in HFD‐control and HFD‐SSE rats were not significantly affected, while creatinine levels only increased after 8 weeks of SSE treatment in HFD rats. Importantly, SSE treatment significantly increased catalase and NQO1 expression in HFD‐fed rat liver. Collectively, these results suggested that diCQA‐rich SSE may offer beneficial effects for the management of obesity and associated metabolic disorders.

  • Open Access

    Nasal Delivery of Asiatic Acid Ameliorates Scopolamine‐Induced Memory Dysfunction in Mice

    by Su Lwin Lwin Myint, Ratchanee Rodsiri, Hattaya Benya-Aphikul, Tissana Rojanaratha, Garnpimol Ritthidej, Ridho Islamie

    Asiatic acid (AA) has previously shown its neuroprotective effects, but low oral bioavailability limits its penetration into the brain. This study aimed to investigate the effect of intranasal AA administration in mice with memory dysfunction induced by scopolamine. Mice received either intranasal AA (INAA), oral AA (POAA3 or POAA30), or donepezil, followed by scopolamine for 10 days. Morris water maze (MWM) was performed on days 0–5, 30 min after treatment. Locomotor activity was conducted on day 6 followed by brain collection. In MWM, INAA treatment had significantly reduced escape latency on days 2–4, while POAA3 decreased escape latency on day 3 and POAA30 and donepezil decreased escape latency on day 4. INAA inhibited acetylcholinesterase activity, increased catalase protein expression, and decreased malondialdehyde levels in the brain tissue. Therefore, intranasal administration of AA produced a rapid onset in the protection of learning and memory deficits induced by scopolamine through acetylcholinesterase inhibition and antioxidant effect.


  • Open Access

    Construction of network pharmacology-based approach and potential mechanism from major components of Coriander sativum L. against COVID-19

    by Ridho Islamie, Iksen Iksen, Bayu Cakra Buana, Kasta Gurning, Hariyadi Dharmawan Syahputra, Hanafis Sastra Winata

    Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Despite the fact that various therapeutic compounds have shown potential prevention or treatment, no specific medicine has been developed for the COVID-19 pandemic. Natural products have recently been suggested as a possible treatment option for COVID-19 prevention and treatment. This study focused on the potential of Coriander sativum L. (CSL) against COVID-19 based on network pharmacology approach. Interested candidates of CSL were identified by searching accessible databases for protein–protein interactions with the COVID-19. An additional GO and KEGG pathway analysis was carried out in order to identify the related mechanism of action. In the end, 51 targets were obtained through network pharmacology analysis with EGFR, AR, JAK2, PARP1, and CTSB become the core target. CSL may have favorable effects on COVID-19 through a number of important pathways, according to GO and KEGG pathway analyses. These findings suggest that CSL may prevent and inhibit the several processes related to COVID-19.


  • Evaluation of stability and quality characteristics of moringa (Moringa oleifera) herbal tea during storage

    by N.I.E. Jayani, M.R. Hean, N.L.A. Krisnayanthi, R. Islamie, K.C. Rani, N. Parfati

    Determining the product’s shelf life was necessary to ensure its quality, effectiveness, and safety. This study aimed to determine the stability of moringa tea products. The real-time stability test was carried out at room temperature (28.5‒33.5°C) with 50‒75% relative humidity, and the sampling interval was once every third month (Month-0, Month-3 and Month-6). Physical parameters (organoleptic properties and moisture content), chemical parameters (total phenolic content and total flavonoid content), and microbial parameters (total plate count and total yeast and mould count) were measured using the standard procedures. The organoleptic test showed no changes in colour, taste, smell, and shape of the teabag and brewed tea products up to the sixth month of evaluation. However, there were significant changes in the moisture content (MC), total phenolic content (TPhC), and total plate count (TPC) of the teabag and only in the TPhC of the brewed tea product throughout the quality control. Physical, chemical, and microbial parameters still met the quality requirements set by the Pharmacopoeia Herbal Indonesia and the Indonesian Food and Drug Authority. The qualities of moringa tea bags and brewed moringa teas stored at room temperature (28.5‒33.5°C) and 50‒75% relative humidity showed good physicochemical properties and stability in the test during six months of observation.


  • Open Access

    SUBCHRONIC ORAL TOXICITY TEST FOR 28 DAYS OF SAUROPUS ANDROGYNOUS L. MERR. LEAVES SOUP IN WISTAR FEMALE RATS

    by Aguslina Kirtishanti, Ridho Islamie

    Objective: The objective of the study was to evaluate the subchronic toxicity of Sauropus androgynus L. Merr. leaves soup. Methods: Subchronic oral toxicity tests were carried out for 28 days in female Wistar rats using conventional methods. Thirty rats were divided into six groups, namely, one control group and three test groups with each extract being given at a dose of 500 mg/kg body weight (BW), 1000 mg/kg BW, and 3000 mg/kg BW, and one group satellite control and satellite test group with doses of 3000 mg/kg BW were carried out for 14 days after 28 days of treatment to see the effects of reversibility. All rat groups were observed for behavior, development of BW, serum glutamic pyruvic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), creatinine serum, ratio of liver and lung organs to BW, and histology of liver and lung. Results: The macroscopic observation of rat’s lung and rat weight ratio did not show a significant difference to the control group (p>0.05). In addition, the ratio of liver volume to BW was significantly different between the doses of 1000 mg/kg BW and 3000 mg/kg BW with satellite groups 3000 mg/kg BW (p0.05). However, creatinine serum had the highest increase at a dose of 500 mg/kg BW and a dose of 1000 mg/kg BW. Reversibility effects were not seen after 14 days of the past day given Sauropus androgynous soup for 28 days in female Wistar rats. Conclusion: The given of S. androgynous soup for 28 days for female Wistar rats did not show any specific toxicity effect so that its use was relatively safe for the consumption under 30 days. This study is expected to be the information source about the safety profile of S. androgynus leaves soup consumption.